ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864,185 | +743.5% | 19,908 | +955.0% | 0.01% | +800.0% |
| Q1 2022 | $221,000 | -64.8% | 1,887 | -59.5% | 0.00% | -66.7% |
| Q4 2021 | $627,000 | -38.1% | 4,659 | -26.7% | 0.00% | -57.1% |
| Q3 2021 | $1,013,000 | +8.1% | 6,354 | +13.1% | 0.01% | -12.5% |
| Q4 2020 | $937,000 | -14.0% | 5,618 | -20.4% | 0.01% | -11.1% |
| Q3 2020 | $1,089,000 | +6.0% | 7,057 | +1.7% | 0.01% | -25.0% |
| Q2 2020 | $1,027,000 | -78.2% | 6,941 | -79.5% | 0.01% | -87.0% |
| Q4 2019 | $4,702,000 | +100.4% | 33,800 | +38.7% | 0.09% | +124.4% |
| Q3 2019 | $2,346,000 | +885.7% | 24,361 | +1076.9% | 0.04% | +485.7% |
| Q2 2019 | $238,000 | -70.5% | 2,070 | -69.9% | 0.01% | -70.8% |
| Q1 2019 | $808,000 | – | 6,866 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |